These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29133129)

  • 1. HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element.
    Zhou T; Block T; Liu F; Kondratowicz AS; Sun L; Rawat S; Branson J; Guo F; Steuer HM; Liang H; Bailey L; Moore C; Wang X; Cuconatti A; Gao M; Lee ACH; Harasym T; Chiu T; Gotchev D; Dorsey B; Rijnbrand R; Sofia MJ
    Antiviral Res; 2018 Jan; 149():191-201. PubMed ID: 29133129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host RNA quality control as a hepatitis B antiviral target.
    Block TM; Young JAT; Javanbakht H; Sofia MJ; Zhou T
    Antiviral Res; 2021 Feb; 186():104972. PubMed ID: 33242518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA.
    Liu F; Lee ACH; Guo F; Kondratowicz AS; Micolochick Steuer HM; Miller A; Bailey LD; Wang X; Chen S; Kultgen SG; Cuconati A; Cole AG; Gotchev D; Dorsey BD; Rijnbrand R; Lam AM; Sofia MJ; Gao M
    J Virol; 2021 Aug; 95(18):e0057421. PubMed ID: 34191584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice.
    Ying RS; Zhu C; Fan XG; Li N; Tian XF; Liu HB; Zhang BX
    Antiviral Res; 2007 Jan; 73(1):24-30. PubMed ID: 16844238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression.
    Chu X; Wu B; Fan H; Hou J; Hao J; Hu J; Wang B; Liu G; Li C; Meng S
    Antiviral Res; 2016 Mar; 127():41-9. PubMed ID: 26784393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
    Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
    J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus genetic diversity.
    Echevarría JM; Avellón A
    J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.
    Gordien E; Rosmorduc O; Peltekian C; Garreau F; Bréchot C; Kremsdorf D
    J Virol; 2001 Mar; 75(6):2684-91. PubMed ID: 11222692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
    Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
    Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro.
    Huang RL; Chen CC; Huang YL; Hsieh DJ; Hu CP; Chen CF; Chang C
    Hepatology; 1996 Sep; 24(3):508-15. PubMed ID: 8781315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
    Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
    Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA.
    Liu Y; Nie H; Mao R; Mitra B; Cai D; Yan R; Guo JT; Block TM; Mechti N; Guo H
    PLoS Pathog; 2017 Apr; 13(4):e1006296. PubMed ID: 28399146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate.
    Charuworn P; Hengen PN; Aguilar Schall R; Dinh P; Ge D; Corsa A; Reesink HW; Zoulim F; Kitrinos KM
    J Hepatol; 2015 May; 62(5):1033-9. PubMed ID: 25514556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.
    Huang H; Zhou W; Zhu H; Zhou P; Shi X
    Toxicol Appl Pharmacol; 2017 May; 323():36-43. PubMed ID: 28322895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.
    Leong CR; Funami K; Oshiumi H; Mengao D; Takaki H; Matsumoto M; Aly HH; Watashi K; Chayama K; Seya T
    Oncotarget; 2016 Oct; 7(42):68179-68193. PubMed ID: 27626689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
    Fernández-Galindo DA; Sánchez-Ávila F; Bobadilla-Morales L; Gómez-Quiróz P; Bueno-Topete M; Armendáriz-Borunda J; Sánchez-Orozco LV
    J Med Virol; 2015 Jun; 87(6):985-92. PubMed ID: 25732900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dihydroquinolizinone Compound RG7834 Inhibits the Polyadenylase Function of PAPD5 and PAPD7 and Accelerates the Degradation of Matured Hepatitis B Virus Surface Protein mRNA.
    Sun L; Zhang F; Guo F; Liu F; Kulsuptrakul J; Puschnik A; Gao M; Rijnbrand R; Sofia M; Block T; Zhou T
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of destruxin B on hepatitis B virus surface antigen gene expression in human hepatoma cells.
    Chen HC; Chou CK; Sun CM; Yeh SF
    Antiviral Res; 1997 May; 34(3):137-44. PubMed ID: 9191021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.
    Cheng HR; Kao JH; Wu HL; Chen TC; Tseng TC; Liu CH; Su TH; Chen PJ; Chen DS; Liu CJ
    Liver Int; 2014 Jul; 34(6):e71-9. PubMed ID: 24119014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.